De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.
about
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).Advances in antibiotic therapy in the critically illWhat's new in multidrug-resistant pathogens in the ICU?The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship.Collaborative approach of individual participant data of prospective studies of de-escalation in non-immunosuppressed critically ill patients with sepsis.Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conferenceEvaluation of early antimicrobial therapy adaptation guided by the BetaLACTA® test: a case-control study.Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.A Simulation Study Reveals Lack of Pharmacokinetic/Pharmacodynamic Target Attainment in De-escalated Antibiotic Therapy in Critically Ill PatientsManagement of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.Empiric antimicrobial therapy in severe sepsis and septic shock: optimizing pathogen clearanceBenefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programsEfficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.Antimicrobial de-escalation of treatment for healthcare-associated pneumonia within the Veterans Healthcare AdministrationCharacteristics and outcomes of anti-infective de-escalation during health care-associated intra-abdominal infectionsBloodstream infections in the Intensive Care Unit.Bloodstream infections in neutropenic cancer patients: A practical update.Impaired Granuloma Formation in Sepsis: Impact of MonocytopeniaDeterminants of Deescalation Failure in Critically Ill Patients with Sepsis: A Prospective Cohort Study.(1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin.Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria.Management of severe sepsis: advances, challenges, and current status.Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting.A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to Enterobacteriaceae (SIMPLIFY): a study protocol for a multicentre, open-label, phase III randomised, controlled, non-inferioritInfectious diseases consultations can make the difference: a brief review and a plea for more infectious diseases specialists in Germany.The use and risks of antibiotics in critically ill patients.Impact of antibiotic de-escalation on clinical outcomes in community-acquired pneumococcal pneumonia.Unmet needs in the management of intra-abdominal infections.De-escalation, adequacy of antibiotic therapy and culture positivity in septic patients: an observational study.Antibiotic de-escalation: observational causal inference and culture dependence.Rapid identification of antimicrobial resistance patterns allows a faster antibiotic adequacy.Antibiotic stewardship: do not rely on de-escalation alone.Focus on adequate antimicrobial treatment and de-escalation in the ICU.Impact of de-escalation of beta-lactam antibiotics on the emergence of antibiotic resistance in ICU patients: a retrospective observational study.[Bacterial sepsis : Diagnostics and calculated antibiotic therapy].The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).[Antibiotic stewardship : Measures for optimizing prescription of anti-infective agents].
P2860
Q26739860-1CBE3B1B-642A-41ED-AE4E-229F82815DE7Q26749328-2534DAA2-195E-4949-8B1B-19E89C23604AQ28071346-CFA27B47-081C-46AB-B7F3-69318B2BEDC0Q30238578-823ABC4F-65DD-44D6-99B1-4BB623052C2FQ31171527-8E929FA4-B0D1-4B03-B813-DF7D0BBC83B6Q33640559-26B5ECAA-D6BE-4A40-B1E4-57FFCB96C463Q33846503-CABD6460-51B8-4173-9C18-845F5F8B33D5Q35816268-0F0BDE89-2FFF-4E58-B497-AF3EDE6C64DFQ35860038-A9E4B46C-D115-4C57-99F8-3CCF0A88CC4DQ36078359-4370BE88-2D6A-4F34-8FC3-C0240F6C4075Q36089167-AA580F9B-81FC-49B0-B51A-799AD66B27D6Q36275773-E234CA75-E3F7-4023-9959-E232342FAA8EQ36294413-677A49BC-D7DB-4096-B96A-57AC17DFBB31Q36455347-7D63D60E-2271-49EB-9B18-7AE03832570EQ36774787-D6F152AE-BB3A-49B5-A141-47F7B91B3CA3Q36913336-2BEDCA52-757F-42BB-8995-3560A078AB37Q36913345-37676DBB-2167-434E-975C-16FCA3178E69Q37115379-B7D5744E-702B-42B1-94C9-B890E6F73F68Q37132283-C46B1005-1750-4E90-8D47-96A5190074E9Q37225323-9F92E810-04C6-4697-BE1A-EA4AF638B3D7Q37646566-6572A7E7-B7F6-4C94-98E5-F90F2904197EQ38384662-8215C98A-56D3-4AD6-B722-F82C103C2C40Q38450665-D1D1DAB5-20AC-4FC2-97B3-923B2ECE7780Q38528292-C5B14DB3-A34C-4B36-8689-EF8DBF6EE353Q38550893-C295D5E1-2194-46E5-AB52-6305B766408FQ38679343-CA097532-C0BA-4EC2-80E1-BD8ABC7647D4Q38732091-5FC4F948-935D-4B79-A02D-14D26961E800Q38747527-D0E74BAA-2A2A-42BC-AF20-A2649A1289F0Q38767901-309E2C83-1AEC-40A8-B5FC-9E1789899389Q39231468-1542B87B-7413-4283-8B7C-862D0AAB8205Q40079705-245BA77C-F786-4A80-B821-83B5FEEF5F58Q40540723-33F9F7E6-4D30-4BEB-AE27-CE675B954CE3Q41644579-9E5EC2B4-9831-404E-BC90-7C0CC24AE36DQ42343353-9E47E008-8B59-4205-92FA-00F97E8A4D8CQ48126976-8A5651C1-C14C-4EFD-B38B-FEF2B8F396ECQ48328989-C58C2919-D266-4456-AEE6-6B4EB0970F3CQ49061695-8B20B8E2-CBBB-44A5-85C3-AA6BCA181839Q49589601-F7307CDB-D7EC-481B-A27A-87CB1C4970AEQ50052469-B281D85F-63F0-4C3A-852B-8C6E5771B23AQ50128182-58497009-BFBB-4C70-8B24-B556129534C3
P2860
De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
De-escalation versus continuat ...... ndomized noninferiority trial.
@en
De-escalation versus continuat ...... ndomized noninferiority trial.
@nl
type
label
De-escalation versus continuat ...... ndomized noninferiority trial.
@en
De-escalation versus continuat ...... ndomized noninferiority trial.
@nl
prefLabel
De-escalation versus continuat ...... ndomized noninferiority trial.
@en
De-escalation versus continuat ...... ndomized noninferiority trial.
@nl
P2093
P2860
P1476
De-escalation versus continuat ...... ndomized noninferiority trial.
@en
P2093
AZUREA Network Investigators
Alain Lepape
Bernard Allaouchiche
Carole Bechis
Claude Martin
François Antonini
Jacques Albanèse
Jean-Michel Constantin
Jean-Yves Lefrant
Julien Textoris
P2860
P2888
P304
P356
10.1007/S00134-014-3411-8
P577
2014-08-05T00:00:00Z